Home › Compare › MDGS vs EQR

MDGS vs EQR: Dividend Comparison 2026

MDGS yields 36.02% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MDGS wins by $138.4K in total portfolio value
10 years
MDGS
MDGS
● Live price
36.02%
Share price
$2.36
Annual div
$0.85
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$186.2K
Annual income
$28,812.90
Full MDGS calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — MDGS vs EQR

📍 MDGS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDGSEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDGS + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MDGS pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDGS
Annual income on $10K today (after 15% tax)
$3,061.44/yr
After 10yr DRIP, annual income (after tax)
$24,490.97/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, MDGS beats the other by $19,836.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDGS + EQR for your $10,000?

MDGS: 50%EQR: 50%
100% EQR50/50100% MDGS
Portfolio after 10yr
$117.0K
Annual income
$17,144.25/yr
Blended yield
14.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

MDGS
No analyst data
Altman Z
3.0
Piotroski
4/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDGS buys
0
EQR buys
0
No recent congressional trades found for MDGS or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDGSEQR
Forward yield36.02% ✓5.87%
Annual dividend / share$0.85$3.47 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$186.2K ✓$47.8K
Annual income after 10y$28,812.90 ✓$5,475.61
Total dividends collected$135.6K ✓$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: MDGS vs EQR ($10,000, DRIP)

YearMDGS PortfolioMDGS Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$14,302$3,601.69$11,380$679.82+$2.9K → MDGS
2$20,117$4,814.05$13,014$837.25+$7.1K → MDGS
3$27,854$6,328.48$14,961$1,036.20+$12.9K → MDGS
4$37,992$8,189.09$17,297$1,289.22+$20.7K → MDGS
5$51,091$10,439.22$20,121$1,613.15+$31.0K → MDGS
6$67,787$13,119.97$23,561$2,030.84+$44.2K → MDGS
7$88,801$16,268.72$27,783$2,573.54+$61.0K → MDGS
8$114,935$19,917.71$33,013$3,284.39+$81.9K → MDGS
9$147,073$24,092.90$39,547$4,223.51+$107.5K → MDGS
10$186,181$28,812.90$47,791$5,475.61+$138.4K → MDGS

MDGS vs EQR: Complete Analysis 2026

MDGS — Stock

Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops wireless vehicle battery charging technologies and modular electronic vehicles. The company was formerly known as Medigus Ltd. and changed its name to Xylo Technologies Ltd in April 2024. Xylo Technologies Ltd was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

Full MDGS Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this MDGS vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDGS vs SCHDMDGS vs JEPIMDGS vs OMDGS vs KOMDGS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.